|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mayr R, Fritsche HM and Pycha A and Pycha
A: Radical cystectomy and the implications of comorbidity. Expert
Rev Anticancer Ther. 14:289–295. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maniotis AJ, Folberg R, Hess A, Seftor EA,
Gardner LM, Pe'er J, Trent JM, Meltzer PS and Hendrix MJ: Vascular
channel formation by human melanoma cells in vivo and in vitro:
Vasculogenic mimicry. Am J Pathol. 155:739–752. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ahmadi SA, Moinfar M, Gohari Moghaddam K
and Bahadori M: Practical application of angiogenesis and
vasculogenic mimicry in prostatic adenocarcinoma. Arch Iran Med.
13:498–503. 2010.PubMed/NCBI
|
|
6
|
Ma JL, Han SX, Zhu Q, Zhao J, Zhang D,
Wang L and Lv Y: Role of twist in vasculogenic mimicry formation in
hypoxic hepatocellular carcinoma cells in vitro. Biochem Biophys
Res Commun. 408:686–691. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Karroum A, Mirshahi P, Faussat AM,
Therwath A, Mirshahi M and Hatmi M: Tubular network formation by
adriamycin-resistant MCF-7 breast cancer cells is closely linked to
MMP-9 and VEGFR-2/VEGFR-3 over-expressions. Eur J Pharmacol.
685:1–7. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu Z, Sun B, Qi L, Li H, Gao J and Leng
X: Zinc finger E-box binding homeobox 1 promotes vasculogenic
mimicry in colorectal cancer through induction of
epithelial-to-mesenchymal transition. Cancer Sci. 103:813–820.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu Q, Qiao L, Liang N, Xie J and Zhang J,
Deng G, Luo H and Zhang J: The relationship between vasculogenic
mimicry and epithelial-mesenchymal transitions. J Cell Mol Med.
20:1761–1769. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang H, Lin H, Pan J, Mo C, Zhang F, Huang
B, Wang Z, Chen X, Zhuang J, Wang D and Qiu S: Vasculogenic mimicry
in prostate cancer: The roles of EphA2 and PI3K. J Cancer.
7:1114–1124. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang P, Sun Y and Ma L: ZEB1: At the
crossroads of epithelial-mesenchymal transition, metastasis and
therapy resistance. Cell Cycle. 14:481–487. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen H, Lu W, Huang C, Ding K, Xia D, Wu Y
and Cai M: Prognostic significance of ZEB1 and ZEB2 in digestive
cancers: A cohort-based analysis and secondary analysis.
Oncotarget. 8:31435–31448. 2017.PubMed/NCBI
|
|
13
|
Hanrahan K, O'Neill A, Prencipe M, Bugler
J, Murphy L, Fabre A, Puhr M, Culig Z, Murphy K and Watson RW: The
role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in
mediating docetaxel-resistant prostate cancer. Mol Oncol.
11:251–265. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Larsen JE, Nathan V, Osborne JK, Farrow
RK, Deb D, Sullivan JP, Dospoy PD, Augustyn A, Hight SK, Sato M, et
al: ZEB1 drives epithelial-to-mesenchymal transition in lung
cancer. J Clin Invest. 126:3219–3235. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang W, Lin P, Sun B, Zhang S, Cai W, Han
C, Li L, Lu H and Zhao X: Epithelial-mesenchymal transition
regulated by EphA2 contributes to vasculogenic mimicry formation of
head and neck squamous cell carcinoma. Biomed Res Int.
2014:8039142014.PubMed/NCBI
|
|
16
|
Cao Z, Sun B, Zhao X, Zhang Y, Gu Q, Liang
X, Dong X and Zhao N: The expression and functional significance of
Runx2 in hepatocellular carcinoma: Its role in vasculogenic mimicry
and epithelial-mesenchymal transition. Int J Mol Sci. 18:pii:
E5002017. View Article : Google Scholar
|
|
17
|
Yang Z, Sun B, Li Y, Zhao X, Zhao X, Gu Q,
An J, Dong X, Liu F and Wang Y: ZEB2 promotes vasculogenic mimicry
by TGF-β1 induced epithelial-to-mesenchymal transition in
hepatocellular carcinoma. Exp Mol Pathol. 98:352–359. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu K, Fan J, Zhang L, Ning Z, Zeng J, Zhou
J, Li L, Chen Y, Zhang T, Wang X, et al: PI3K/Akt to
GSK3β/β-catenin signaling cascade coordinates cell colonization for
bladder cancer bone metastasis through regulating ZEB1
transcription. Cell Signal. 24:2273–2282. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mahdavinezhad A, Yadegarazari R,
Mousavi-Bahar SH, Poorolajal J, Jafari M, Amirzargar MA, Effatpanah
H and Saidijam M: Evaluation of zinc finger E-box binding homeobox
1 and transforming growth factor-beta2 expression in bladder cancer
tissue in comparison with healthy adjacent tissue. Investig Clin
Urol. 58:140–145. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kenney PA, Wszolek MF, Rieger-Christ KM,
Neto BS, Gould JJ, Harty NJ, Mosquera JM, Zeheb R, Loda M, Darling
DS, et al: Novel ZEB1 expression in bladder tumorigenesis. BJU Int.
107:656–663. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu B, Miyake H, Nishikawa M and Fujisawa
M: Expression profile of epithelial-mesenchymal transition markers
in non-muscle-invasive urothelial carcinoma of the bladder:
Correlation with intravesical recurrence following transurethral
resection. Urol Oncol. 33:110.e11–8. 2015. View Article : Google Scholar
|
|
22
|
Xu Y, Li Q, Li XY, Yang QY, Xu WW and Liu
GL: Short-term anti-vascular endothelial growth factor treatment
elicits vasculogenic mimicry formation of tumors to accelerate
metastasis. J Exp Clin Cancer Res. 31:162012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu L, Wu S, Zhou L, Song W and Wang D:
Expressions of CD133 and CD82/KAI1 in bladder urothelial carcinoma
and their correlation with vasculogenic mimicry. Nan Fang Yi Ke Da
Xue Xue Bao. 33:1336–1340. 2013.(In Chinese). PubMed/NCBI
|
|
24
|
Zhou L, Chang Y, Xu L, Hoang ST, Liu Z, Fu
Q, Lin Z and Xu J: Prognostic value of vascular mimicry in patients
with urothelial carcinoma of the bladder after radical cystectomy.
Oncotarget. 7:76214–76223. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang X, Wu Q, Xu B, Wang P, Fan W, Cai Y,
Gu X and Meng F: MiR-124 exerts tumor suppressive functions on the
cell proliferation, motility and angiogenesis of bladder cancer by
fine-tuning UHRF1. FEBS J. 282:4376–4388. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
LI H, Song S, Xu Y, Zhao J and Liu H:
Knockdown of ZEB1 suppresses the formation of vasculogenic mimicry
in breast cancer cell line MDA-MB-231 through downregulation of
Flk-1. Minerva Med. 108:191–193. 2017.PubMed/NCBI
|
